Sumocor LLC Profile last edited on: 11/30/2017
CAGE: 7C251
UEI: KT53C2WERLQ7
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 09
County: Bergen
Congr. District: 09
County: Bergen
Public Profile
SUMO1 is a so-called chaperone protein that regulates the activity of key transporter genes It has been deternined that SUM01 is decreased in the failing heart suggesting the protien may play a critical role in the pathogenesis of heart failure. The founding of Sumocor LLC and the firm's research focus comes out of, and builds on, the research findings of the firm's President and CEO at the Icahn School of Medicine at Mount Sinai when it was discovered that if SUMO1 was injected into failing preclinical models via gene therapy, a significant improvement of cardiac function was observed.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2018 | 1 | NIH | $315,000 | |
| Project Title: Developing Small Molecule Therapies for Heart Failure | ||||
| 2018 | 1 | NIH | $240,751 | |
| Project Title: Novel Sumo Activators for the Treatment of Duchenne Muscular Dystrophy-Associated Heart Failure | ||||
| 2018 | 2 | NIH | $1,698,530 | |
| Project Title: Small Molecule Therapy for the Treatment of Heart Failure | ||||
Key People / Management
Roger J Hajjar -- President and CEO
Blake A Adair-Wheeler -- Chief Administrative Officer
Djamel Lebeche
Ahyoung Lee
Blake A Adair-Wheeler -- Chief Administrative Officer
Djamel Lebeche
Ahyoung Lee
Company News
There are no news available.
